N substituted 3-amino-2,2-di-c-alkyl-1,4-butyrolactones and 1,4-thiobutyrolactones for use as promoter of γ-aminobutyric acid activity and for treating nervous disorders and preparation method
AssigneesCentre National de la Recherche Scientifique (CNRS), Innovationsagentur GmbH, Universite de Bern
InventorsRobert Dodd, Ahmed El Hadri, Jean-Paul Pierre Potier, Werner Sieghart, Frantisek Jursky, Roman Furtmuller, Erwin Sigel, Urs Thomet
Life of this patent
Estimating the term…